vs
德康医疗（DXCM）与孩之宝（HAS）财务数据对比。点击上方公司名可切换其他公司
孩之宝的季度营收约是德康医疗的1.1倍（$1.4B vs $1.3B），德康医疗净利率更高（21.2% vs 13.9%，领先7.3%），孩之宝同比增速更快（31.3% vs 21.6%），过去两年孩之宝的营收复合增速更高（38.2% vs 12.0%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
孩之宝是1923年12月6日成立的美国跨国玩具制造与娱乐控股企业，总部位于罗德岛州波塔基特。旗下拥有Kenner、米尔顿·布拉德利、派克兄弟、威世智等知名品牌，持有大量热门IP商标权，业务覆盖玩具生产、游戏开发、娱乐内容出品等多个领域。
DXCM vs HAS — 直观对比
营收规模更大
HAS
是对方的1.1倍
$1.3B
营收增速更快
HAS
高出9.7%
21.6%
净利率更高
DXCM
高出7.3%
13.9%
两年增速更快
HAS
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.4B |
| 净利润 | $267.3M | $201.6M |
| 毛利率 | 62.9% | 68.7% |
| 营业利润率 | 25.6% | 20.6% |
| 净利率 | 21.2% | 13.9% |
| 营收同比 | 21.6% | 31.3% |
| 净利润同比 | 153.6% | 687.8% |
| 每股收益（稀释后） | $0.67 | $1.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMHAS
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $980.8M | ||
| Q1 25 | $1.0B | $887.1M | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $994.2M | $1.3B | ||
| Q2 24 | $1.0B | $995.3M |
净利润DXCMHAS
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $201.6M | ||
| Q3 25 | $283.8M | $233.2M | ||
| Q2 25 | $179.8M | $-855.8M | ||
| Q1 25 | $105.4M | $98.6M | ||
| Q4 24 | $151.7M | $-34.3M | ||
| Q3 24 | $134.6M | $223.2M | ||
| Q2 24 | $143.5M | $138.5M |
毛利率DXCMHAS
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 68.7% | ||
| Q3 25 | 60.5% | 70.1% | ||
| Q2 25 | 59.5% | 77.0% | ||
| Q1 25 | 56.9% | 76.9% | ||
| Q4 24 | 58.9% | 67.4% | ||
| Q3 24 | 59.7% | 70.4% | ||
| Q2 24 | 62.4% | 76.1% |
营业利润率DXCMHAS
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 20.6% | ||
| Q3 25 | 20.1% | 24.6% | ||
| Q2 25 | 18.4% | -81.4% | ||
| Q1 25 | 12.9% | 19.2% | ||
| Q4 24 | 17.0% | 5.4% | ||
| Q3 24 | 15.3% | 23.6% | ||
| Q2 24 | 15.7% | 21.3% |
净利率DXCMHAS
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 13.9% | ||
| Q3 25 | 23.5% | 16.8% | ||
| Q2 25 | 15.5% | -87.3% | ||
| Q1 25 | 10.2% | 11.1% | ||
| Q4 24 | 13.6% | -3.1% | ||
| Q3 24 | 13.5% | 17.4% | ||
| Q2 24 | 14.3% | 13.9% |
每股收益（稀释后）DXCMHAS
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.46 | ||
| Q3 25 | $0.70 | $1.64 | ||
| Q2 25 | $0.45 | $-6.10 | ||
| Q1 25 | $0.27 | $0.70 | ||
| Q4 24 | $0.37 | $-0.25 | ||
| Q3 24 | $0.34 | $1.59 | ||
| Q2 24 | $0.35 | $0.99 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $565.5M |
| 总资产 | $6.3B | $5.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMHAS
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
股东权益DXCMHAS
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $565.5M | ||
| Q3 25 | $2.7B | $433.8M | ||
| Q2 25 | $2.6B | $269.7M | ||
| Q1 25 | $2.3B | $1.2B | ||
| Q4 24 | $2.1B | $1.2B | ||
| Q3 24 | $2.0B | $1.3B | ||
| Q2 24 | $2.4B | $1.2B |
总资产DXCMHAS
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $5.6B | ||
| Q3 25 | $7.5B | $5.5B | ||
| Q2 25 | $7.3B | $5.2B | ||
| Q1 25 | $6.8B | $6.0B | ||
| Q4 24 | $6.5B | $6.3B | ||
| Q3 24 | $6.4B | $7.2B | ||
| Q2 24 | $6.8B | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $403.2M |
| 自由现金流经营现金流 - 资本支出 | — | $389.5M |
| 自由现金流率自由现金流/营收 | — | 26.9% |
| 资本支出强度资本支出/营收 | — | 0.9% |
| 现金转化率经营现金流/净利润 | — | 2.00× |
| 过去12个月自由现金流最近4个季度 | — | $829.9M |
8季度趋势，按日历期对齐
经营现金流DXCMHAS
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $403.2M | ||
| Q3 25 | $659.9M | $280.6M | ||
| Q2 25 | $303.0M | $71.3M | ||
| Q1 25 | $183.8M | $138.1M | ||
| Q4 24 | $301.4M | $259.8M | ||
| Q3 24 | $199.5M | $222.5M | ||
| Q2 24 | $279.4M | $187.3M |
自由现金流DXCMHAS
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $389.5M | ||
| Q3 25 | $579.4M | $260.9M | ||
| Q2 25 | $208.9M | $55.2M | ||
| Q1 25 | $96.8M | $124.3M | ||
| Q4 24 | $176.8M | $200.8M | ||
| Q3 24 | $88.3M | $174.0M | ||
| Q2 24 | $213.3M | $135.4M |
自由现金流率DXCMHAS
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 26.9% | ||
| Q3 25 | 47.9% | 18.8% | ||
| Q2 25 | 18.1% | 5.6% | ||
| Q1 25 | 9.3% | 14.0% | ||
| Q4 24 | 15.9% | 18.2% | ||
| Q3 24 | 8.9% | 13.6% | ||
| Q2 24 | 21.2% | 13.6% |
资本支出强度DXCMHAS
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.9% | ||
| Q3 25 | 6.7% | 1.4% | ||
| Q2 25 | 8.1% | 1.6% | ||
| Q1 25 | 8.4% | 1.6% | ||
| Q4 24 | 11.2% | 5.4% | ||
| Q3 24 | 11.2% | 3.8% | ||
| Q2 24 | 6.6% | 5.2% |
现金转化率DXCMHAS
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 2.00× | ||
| Q3 25 | 2.33× | 1.20× | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | 1.40× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 1.00× | ||
| Q2 24 | 1.95× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
HAS
| Grow Brands | $1.1B | 75% |
| Optimize Brands | $188.7M | 13% |
| Digital And Licensing Gaming | $135.7M | 9% |
| Class Of Principal Product Family Brands | $13.1M | 1% |
| Filmand TV | $2.4M | 0% |
